Philip Morris International Inc (PM) — closed signal from April 28, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on July 27, 2026 — +20% at the close.
Predicted vs. what happened
What happened
Reached its target in 14 days.
The thesis — published April 28, 2026
Philip Morris looks clearer than many consumer staples because growth is coming from smoke-free products and the ZYN oral nicotine brand, while quarterly results were solid. Insider stock sales and the companys debt level reduce confidence, and the stock is not deeply cheap. Near-term setup seems constructive but less exciting than stronger cyclical names.
Primary drivers
- Smoke-free products are shifting sales toward higher-growth items
- ZYN oral nicotine is large enough to move overall sales
- A recent earnings beat shows the business is executing
- Insider selling and higher debt lower conviction
How it played out
PM: target reached in 14 days
Lyra published PM at $163.06 with 12% expected growth and a $181.12 target. The thesis pointed to smoke-free products, the ZYN oral nicotine brand, and solid quarterly results. It also cited insider selling and higher debt as reasons for lower conviction, while noting that the shares were not deeply cheap.
PM reached the target in 14 days. Inside the window, it rose to a $199.78 peak on July 22, a 22.5% gain. It ended at $195.66 on July 27, still above the target and close to the peak. The published thesis played out and exceeded its stated price objective.
What happened during the window
On July 22, 2026, Philip Morris reported second-quarter net revenue of $11.2 billion, up 10.4%, and said smoke-free products made up about 42% of net revenue.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.